找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials; Tony K.L. Kiang,Kyle John Wilby,Mary H.H. En

[復(fù)制鏈接]
樓主: 切口
31#
發(fā)表于 2025-3-26 21:45:11 | 只看該作者
32#
發(fā)表于 2025-3-27 04:14:24 | 只看該作者
The Roles of SUMO in Metabolic Regulationin 108 countries that are inhabited by approximately 3 billion people. The most recent estimates from the World Health Organization (WHO) (WHO 2014a, b) suggest there were approximately 207 million cases of malaria in 2012 and 627,000 deaths related to the disease. Most deaths occurred among childre
33#
發(fā)表于 2025-3-27 07:28:16 | 只看該作者
Amanda C. Nottke,Monica P. Colaiácovonergistic combinations and increased therapeutic success. A summary of pharmacological and pharmacokinetic considerations is given in Table 2.1 for chloroquine, amodiaquine, sulfadoxine, pyrimethamine, mefloquine, quinine/quinidine, artemisinin (the artemisinin agents, artemether, artesunate, and di
34#
發(fā)表于 2025-3-27 10:28:51 | 只看該作者
Sumo Modification of Ion Channelsalarials include the following: chloroquine, amodiaquine, sulfadoxine and pyrimethamine, mefloquine, primaquine, atovaquone, proguanil, quinine, artemisinin, artesunate, artemether, and dihydroartemisin.
35#
發(fā)表于 2025-3-27 15:08:48 | 只看該作者
36#
發(fā)表于 2025-3-27 20:19:16 | 只看該作者
37#
發(fā)表于 2025-3-28 00:13:07 | 只看該作者
Book 2010s.. . .Comprehensive coverage of the new greater and more challenging integration with .NET 3.5 . .Written from a real–world perspective and examines the features offered by LINQ and the Entity Framework that will help solve problems experienced by professional developers . .Contains insight, interp
38#
發(fā)表于 2025-3-28 04:20:10 | 只看該作者
39#
發(fā)表于 2025-3-28 09:00:00 | 只看該作者
40#
發(fā)表于 2025-3-28 12:29:25 | 只看該作者
Der It?-Kalkül978-3-540-29265-4Series ISSN 2731-3557 Series E-ISSN 2731-3565
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 23:18
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
新平| 江山市| 临安市| 运城市| 肃北| 礼泉县| 马尔康县| 时尚| 阜新市| 昂仁县| 渝北区| 城口县| 五华县| 疏附县| 昭通市| 邹平县| 富裕县| 肥西县| 金坛市| 轮台县| 大石桥市| 宝山区| 三穗县| 淄博市| 深泽县| 泸州市| 游戏| 大方县| 海宁市| 临泉县| 改则县| 馆陶县| 梓潼县| 苍南县| 花莲县| 铅山县| 蒲城县| 平原县| 兖州市| 若尔盖县| 伊吾县|